Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Businessweek Archives

Randall L. Tobias


Cover Story -- The Best Managers

RANDALL L. TOBIAS

Since arriving at Eli Lilly four years ago, CEO RANDALL L. TOBIAS has readied a slew of new products. And in '97, he reaped his reward. Lilly has five new drugs to offset its slowing workhorse, Prozac, including a hit drug for schizophrenia, Zyprexa (page 77). Better still, shareholders barely blinked last June when Tobias, 55, took a $2.4 billion write-off on his overpriced purchase of drug-benefits manager PCS Health Systems. The stock rose 92%, to hit an all-time high of 70.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus